Castle Biosciences
CSTL
CSTL
57 hedge funds and large institutions have $88.1M invested in Castle Biosciences in 2019 Q3 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$13.5M |
| 2 |
2
Goldman Sachs
New York
|
$5.46M |
| 3 |
DCM
3
Driehaus Capital Management
Chicago,
Illinois
|
$5.07M |
| 4 |
WA
4
Wasatch Advisors
Salt Lake City,
Utah
|
$4.98M |
| 5 |
5
BlackRock
New York
|
$3.74M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FCM
51
Flinton Capital Management
Philadelphia,
Pennsylvania
| $22K | +$22K | +1,232 | New |
|
|
SO
52
STRS Ohio
Columbus,
Ohio
| $18K | +$18K | +1,000 | New |
|
53
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $16K | +$16K | +1,023 | New |
|
54
Legal & General Group
London,
United Kingdom
| $10K | +$10K | +576 | New |
|
|
AIP
55
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | +$6K | +310 | New |
|
|
CCA
56
Catalyst Capital Advisors
Huntington,
New York
| $5K | +$5K | +300 | New |
|
57
Citigroup
New York
| $3K | +$3K | +163 | New |
|